Breast cancer is hormonally mediated and oestrogens are the prime agents in tumour expression. This was the main conclusion of the meeting in June, 1980, of the Multidisciplinary Project on Breast Cancer of the International Union Against Cancer (Miller and Bulbrook, 1980). The present report conce
Binding of oestradiol to blood proteins and aetiology of breast cancer
β Scribed by J. W. Moore; G. M. G. Clark; S. A. Hoare; R. R. Millis; J. L. Hayward; M. K. Quinlan; D. Y. Wang; R. D. Bulbrook
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- French
- Weight
- 551 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
A prospective study of 5,000 women has shown that, compared to controls, those who subsequently developed breast cancer had a higher proportion of their blood oestradiol in the non-protein-bound and albumin-bound fractions (the bio-available fraction) and a lower proportion in the sex-hormone-bound fraction. The increased proportion of bio-available oestradiol was partly due to a lower concentration of sex-horrnone-binding globulin. Weight was excluded as a confounding factor. 'To whom requests for reprints should be sent.
π SIMILAR VOLUMES
A number of risk factors for breast cancer are considered jointly in one pathogenetic framework which relates to the formation of pre-cancerous lesions. Energy-rich diet during puberty and adolescence enhances the occurrence of pre-cancerous lesions in the breast. This process is counteracted by ful
The binding of fluvastatin, an inhibitor of hydroxymethylglutaryl coenzyme A reductase, to plasma proteins and red blood cells of rat, dog, and human in vitro was determined by ultrafiltration. Additionally, the stereospecificity of fluvastatin binding to proteins and the potential interaction betwe
In premenopausal women with breast cancer. total serum oestradiol (Ed concentrations are normal but nonprotein-bound E, concentrations are significantly raised. This is not due to low sex-hormone-binding-globulin (SHBG) binding capacities which are within the normal range and is unlikely to be due t
## Abstract The distribution of oestradiol in plasma from postβmenopausal women with or without breast cancer has been measured and related to the metabolic clearance rates of oestradiol (MCRβE2). All measurements were carried out preoperatively. No difference in the free fraction of oestradiol was